Clinical trial Recruiting at 3 sites Interventional Ages 45 and up

Continuous versus bolus norepinephrine during anesthesia induction for postinduction hypotension

Official title: Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension in High-Risk Non-Cardiac Surgery Patients - The Multicenter INDUCT Trial (INDUCT-Multi)

Run by Universitätsklinikum Hamburg-Eppendorf · NCT07538388 · Data updated 2026-11-12

This trial will test whether giving norepinephrine as a continuous infusion instead of repeated boluses during induction of general anesthesia reduces low blood pressure in high-risk non-cardiac surgery patients.

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment446 (estimated)
SponsorUniversitätsklinikum Hamburg-Eppendorf
Academic / other
Locations4 sites (Berlin and 3 other locations)
StatusRecruiting
StartedMay 7, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 29, 2026
Trial IDNCT07538388 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are consenting adults (≥45 years) scheduled for elective major non-cardiac surgery with planned continuous radial arterial blood pressure monitoring and at least two specified risk factors for perioperative acute kidney injury.

Probably not a fit

Patients unlikely to benefit include those with a clinical indication for continuous norepinephrine already, active cardiac arrhythmias, pregnancy, certain intracranial conditions, or those unable to consent in German or who will not have arterial line monitoring.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

INDUCT-Multi is a multicenter, randomized comparison of continuous norepinephrine infusion versus repeated bolus dosing started during induction of general anesthesia. The trial enrolls consenting patients aged 45 and older having elective major non-cardiac surgery who will have radial arterial catheter monitoring and carry predefined risk factors for acute kidney injury. Continuous arterial blood pressure monitoring is used during induction and the assigned norepinephrine strategy is applied to maintain blood pressure. The main focus is on reducing the frequency and severity of postinduction hypotension, with secondary interest in downstream organ injury such as acute kidney injury and overall hemodynamic stability.

Why it matters

Potential benefit: If successful, this approach could produce more stable blood pressure during induction and reduce episodes of severe hypotension and related complications such as acute kidney injury.

How similar studies have gone: A prior single-center randomized trial showed improved blood pressure stability with continuous norepinephrine, but multicenter confirmation is limited and this trial seeks broader validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

We will include consenting patients ≥45 years scheduled for elective non-cardiac surgery under general anesthesia with planned continuous intra-arterial blood pressure monitoring with a radial arterial catheter and with at least two of the following risk criteria for developing acute kidney injury:

* Age ≥65 years
* ASA physical status III or IV
* Chronic arterial hypertension
* Diabetes mellitus requiring medication
* Intra-abdominal surgery
* Preoperative renal insufficiency (serum creatinine ≥1.2 mg/dL)

Exclusion Criteria:

* Pregnancy
* Cardiac arrhythmia
* History of intracranial hemorrhage or intracranial aneurysm
* Clinical indication for continuous norepinephrine infusion during induction of general anesthesia (e.g., severe aortic valve stenosis, coronary artery disease, or heart failure)
* Patients who are unable to understand, read, and provide informed consent in German

Where it's running

  • Department of Anesthesiology, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf
    Düsseldorf, Germany
    Recruiting
  • Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf
    Hamburg, Germany
    Recruiting
  • Department of Anaesthesiology, University Hospital LMU Munich
    München, Germany
    Recruiting
  • Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin
    Berlin, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.